ES2627190T3 - Inmunoensayos sensibles utilizando nanopartículas recubiertas - Google Patents
Inmunoensayos sensibles utilizando nanopartículas recubiertas Download PDFInfo
- Publication number
- ES2627190T3 ES2627190T3 ES15172303.8T ES15172303T ES2627190T3 ES 2627190 T3 ES2627190 T3 ES 2627190T3 ES 15172303 T ES15172303 T ES 15172303T ES 2627190 T3 ES2627190 T3 ES 2627190T3
- Authority
- ES
- Spain
- Prior art keywords
- analyte
- liquid sample
- reagent
- test device
- labeled
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002105 nanoparticle Substances 0.000 title claims abstract description 156
- 238000003018 immunoassay Methods 0.000 title description 27
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 176
- 239000012491 analyte Substances 0.000 claims abstract description 133
- 239000007788 liquid Substances 0.000 claims abstract description 125
- 238000001514 detection method Methods 0.000 claims abstract description 123
- 238000012360 testing method Methods 0.000 claims abstract description 91
- 238000001069 Raman spectroscopy Methods 0.000 claims abstract description 49
- 239000003446 ligand Substances 0.000 claims abstract description 47
- 238000009739 binding Methods 0.000 claims abstract description 39
- 230000027455 binding Effects 0.000 claims abstract description 38
- 238000000034 method Methods 0.000 claims abstract description 36
- MCMNRKCIXSYSNV-UHFFFAOYSA-N Zirconium dioxide Chemical compound O=[Zr]=O MCMNRKCIXSYSNV-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000011521 glass Substances 0.000 claims abstract description 28
- 239000002184 metal Substances 0.000 claims abstract description 25
- 229910052751 metal Inorganic materials 0.000 claims abstract description 25
- 238000004891 communication Methods 0.000 claims abstract description 23
- 239000012530 fluid Substances 0.000 claims abstract description 23
- 229920000642 polymer Polymers 0.000 claims abstract description 21
- 239000004793 Polystyrene Substances 0.000 claims abstract description 16
- 229920002223 polystyrene Polymers 0.000 claims abstract description 16
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 15
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims abstract description 15
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 15
- 239000004926 polymethyl methacrylate Substances 0.000 claims abstract description 15
- 229910010293 ceramic material Inorganic materials 0.000 claims abstract description 14
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 77
- 239000012528 membrane Substances 0.000 claims description 70
- 239000010931 gold Substances 0.000 claims description 58
- 229910052737 gold Inorganic materials 0.000 claims description 58
- 239000000020 Nitrocellulose Substances 0.000 claims description 24
- 229920001220 nitrocellulos Polymers 0.000 claims description 24
- 239000002250 absorbent Substances 0.000 claims description 16
- 230000002745 absorbent Effects 0.000 claims description 16
- 241000700605 Viruses Species 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 241000894006 Bacteria Species 0.000 claims description 9
- 102000039446 nucleic acids Human genes 0.000 claims description 9
- 108020004707 nucleic acids Proteins 0.000 claims description 9
- 150000007523 nucleic acids Chemical class 0.000 claims description 9
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- 108090000623 proteins and genes Proteins 0.000 claims description 9
- 229920003023 plastic Polymers 0.000 claims description 8
- 239000004033 plastic Substances 0.000 claims description 8
- 238000004458 analytical method Methods 0.000 claims description 7
- 239000002207 metabolite Substances 0.000 claims description 7
- 150000003384 small molecules Chemical class 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 abstract description 6
- 238000000576 coating method Methods 0.000 abstract description 6
- 239000000523 sample Substances 0.000 description 112
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 84
- 239000000377 silicon dioxide Substances 0.000 description 42
- 239000002245 particle Substances 0.000 description 38
- 230000035945 sensitivity Effects 0.000 description 31
- 208000037797 influenza A Diseases 0.000 description 27
- 239000011257 shell material Substances 0.000 description 27
- 238000003556 assay Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 17
- 239000000084 colloidal system Substances 0.000 description 16
- 238000002474 experimental method Methods 0.000 description 14
- 238000012125 lateral flow test Methods 0.000 description 14
- 239000000463 material Substances 0.000 description 13
- 241000712431 Influenza A virus Species 0.000 description 12
- 230000009471 action Effects 0.000 description 10
- 239000013065 commercial product Substances 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- MWVTWFVJZLCBMC-UHFFFAOYSA-N 4,4'-bipyridine Chemical group C1=NC=CC(C=2C=CN=CC=2)=C1 MWVTWFVJZLCBMC-UHFFFAOYSA-N 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 239000000123 paper Substances 0.000 description 7
- 239000011148 porous material Substances 0.000 description 7
- 239000000758 substrate Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 6
- 238000009792 diffusion process Methods 0.000 description 6
- 239000002082 metal nanoparticle Substances 0.000 description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 description 6
- 241000713196 Influenza B virus Species 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 150000003573 thiols Chemical class 0.000 description 5
- 239000012472 biological sample Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000008393 encapsulating agent Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000000007 visual effect Effects 0.000 description 4
- UUEWCQRISZBELL-UHFFFAOYSA-N 3-trimethoxysilylpropane-1-thiol Chemical compound CO[Si](OC)(OC)CCCS UUEWCQRISZBELL-UHFFFAOYSA-N 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 229920000297 Rayon Polymers 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000011152 fibreglass Substances 0.000 description 3
- 208000037798 influenza B Diseases 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000002964 rayon Substances 0.000 description 3
- 238000002310 reflectometry Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 102000011022 Chorionic Gonadotropin Human genes 0.000 description 2
- 108010062540 Chorionic Gonadotropin Proteins 0.000 description 2
- 206010069767 H1N1 influenza Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000001237 Raman spectrum Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000000919 ceramic Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000003795 desorption Methods 0.000 description 2
- 239000003989 dielectric material Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 229940084986 human chorionic gonadotropin Drugs 0.000 description 2
- 238000005470 impregnation Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- VUFNRPJNRFOTGK-UHFFFAOYSA-M sodium;1-[4-[(2,5-dioxopyrrol-1-yl)methyl]cyclohexanecarbonyl]oxy-2,5-dioxopyrrolidine-3-sulfonate Chemical compound [Na+].O=C1C(S(=O)(=O)[O-])CC(=O)N1OC(=O)C1CCC(CN2C(C=CC2=O)=O)CC1 VUFNRPJNRFOTGK-UHFFFAOYSA-M 0.000 description 2
- 230000009870 specific binding Effects 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 201000010740 swine influenza Diseases 0.000 description 2
- -1 that is Substances 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- JGSSBWAWLXYSMC-UHFFFAOYSA-N 1-chloro-7,9-dihydro-3h-purine-2,6,8-trione Chemical compound O=C1N(Cl)C(=O)NC2=C1NC(=O)N2 JGSSBWAWLXYSMC-UHFFFAOYSA-N 0.000 description 1
- DCQBZYNUSLHVJC-UHFFFAOYSA-N 3-triethoxysilylpropane-1-thiol Chemical compound CCO[Si](OCC)(OCC)CCCS DCQBZYNUSLHVJC-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000606161 Chlamydia Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000009889 Herpes Simplex Diseases 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000009151 Luteinizing Hormone Human genes 0.000 description 1
- 108010073521 Luteinizing Hormone Proteins 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- BOTDANWDWHJENH-UHFFFAOYSA-N Tetraethyl orthosilicate Chemical compound CCO[Si](OCC)(OCC)OCC BOTDANWDWHJENH-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000004931 aggregating effect Effects 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 238000002820 assay format Methods 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 230000009137 competitive binding Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- IDLFZVILOHSSID-OVLDLUHVSA-N corticotropin Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)NC(=O)[C@@H](N)CO)C1=CC=C(O)C=C1 IDLFZVILOHSSID-OVLDLUHVSA-N 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 239000012897 dilution medium Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229940040129 luteinizing hormone Drugs 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 229910052976 metal sulfide Inorganic materials 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 238000013387 non optimize process Methods 0.000 description 1
- 239000013110 organic ligand Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 235000013446 pixi Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000000700 radioactive tracer Substances 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000006557 surface reaction Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000006177 thiolation reaction Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54388—Immunochromatographic test strips based on lateral flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
- G01N33/54391—Immunochromatographic test strips based on vertical flow
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
- G01N33/587—Nanoparticles
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Nanotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7103508P | 2008-04-09 | 2008-04-09 | |
| US71035P | 2008-04-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2627190T3 true ES2627190T3 (es) | 2017-07-27 |
Family
ID=40756968
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15172303.8T Active ES2627190T3 (es) | 2008-04-09 | 2009-04-08 | Inmunoensayos sensibles utilizando nanopartículas recubiertas |
| ES09730869.6T Active ES2544257T3 (es) | 2008-04-09 | 2009-04-08 | Inmunoensayos sensibles usando nanopartículas recubiertas |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES09730869.6T Active ES2544257T3 (es) | 2008-04-09 | 2009-04-08 | Inmunoensayos sensibles usando nanopartículas recubiertas |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20090305231A1 (enExample) |
| EP (2) | EP2271939B1 (enExample) |
| JP (3) | JP5792614B2 (enExample) |
| CN (2) | CN102016585B (enExample) |
| AU (1) | AU2009233755B2 (enExample) |
| BR (1) | BRPI0911067B8 (enExample) |
| CA (1) | CA2721064C (enExample) |
| ES (2) | ES2627190T3 (enExample) |
| MX (1) | MX2010011176A (enExample) |
| TW (1) | TW200946913A (enExample) |
| WO (1) | WO2009126735A1 (enExample) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090291508A1 (en) * | 2008-05-20 | 2009-11-26 | Rapid Pathogen Screening Inc. | Nanoparticles in diagnostic tests |
| US8470608B2 (en) * | 2008-05-20 | 2013-06-25 | Rapid Pathogen Screening, Inc | Combined visual/fluorescence analyte detection test |
| US8669052B2 (en) | 2008-06-10 | 2014-03-11 | Rapid Pathogen Screening, Inc. | Lateral flow nucleic acid detector |
| US8609433B2 (en) | 2009-12-04 | 2013-12-17 | Rapid Pathogen Screening, Inc. | Multiplanar lateral flow assay with sample compressor |
| US8962260B2 (en) | 2008-05-20 | 2015-02-24 | Rapid Pathogen Screening, Inc. | Method and device for combined detection of viral and bacterial infections |
| US9068981B2 (en) | 2009-12-04 | 2015-06-30 | Rapid Pathogen Screening, Inc. | Lateral flow assays with time delayed components |
| US20130196310A1 (en) | 2008-05-20 | 2013-08-01 | Rapid Pathogen Screening, Inc. | Method and Device for Combined Detection of Viral and Bacterial Infections |
| US8815609B2 (en) | 2008-05-20 | 2014-08-26 | Rapid Pathogen Screening, Inc. | Multiplanar lateral flow assay with diverting zone |
| US20110086359A1 (en) | 2008-06-10 | 2011-04-14 | Rapid Pathogen Screening, Inc. | Lateral flow assays |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10338069B2 (en) * | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| WO2012051218A2 (en) * | 2010-10-11 | 2012-04-19 | Mbio Diagnostics, Inc. | Fluidic assay cartridge with controlled passive flow |
| US10114020B2 (en) | 2010-10-11 | 2018-10-30 | Mbio Diagnostics, Inc. | System and device for analyzing a fluidic sample |
| CA2778561C (en) * | 2011-05-31 | 2020-10-13 | Ghandi, Khashayar | Magnetic nanocomposite material and processes for the production thereof |
| US9715579B2 (en) | 2011-09-09 | 2017-07-25 | Alverix, Inc. | Distributed network of in-vitro diagnostic devices |
| US9524372B2 (en) | 2011-09-09 | 2016-12-20 | Alverix, Inc. | In-vitro diagnostic device using external information in conjunction with test results |
| US10725033B2 (en) * | 2012-01-31 | 2020-07-28 | Regents Of The University Of Minnesota | Lateral flow assays with thermal contrast readers |
| US10816492B2 (en) * | 2012-01-31 | 2020-10-27 | Regents Of The University Of Minnesota | Lateral flow assays with thermal contrast readers |
| EP2884264B1 (en) | 2012-08-10 | 2019-11-20 | Hamamatsu Photonics K.K. | Surface-enhanced raman scattering element, and method for producing same |
| CN104508466B (zh) | 2012-08-10 | 2018-07-17 | 浜松光子学株式会社 | 表面增强拉曼散射元件 |
| JP6151948B2 (ja) * | 2013-03-29 | 2017-06-21 | 浜松ホトニクス株式会社 | 表面増強ラマン散乱ユニット及びラマン分光分析方法 |
| EP2911791A4 (en) | 2012-10-29 | 2016-11-02 | Mbio Diagnostics Inc | BIOPARTICLE IDENTIFICATION SYSTEM, CARTRIDGE AND RELATED METHODS |
| EP2811301B1 (en) | 2012-11-15 | 2017-05-10 | Ortho-Clinical Diagnostics, Inc. | Quality/process control of a lateral flow assay device based on flow monitoring |
| KR102298172B1 (ko) | 2013-09-06 | 2021-09-06 | 아카데미아 시니카 | 변화된 글리코실 그룹을 갖는 당지질을 사용한 인간 iNKT 세포 활성화 |
| US10005847B2 (en) | 2014-05-27 | 2018-06-26 | Academia Sinica | Anti-HER2 glycoantibodies and uses thereof |
| KR20240096599A (ko) | 2014-05-27 | 2024-06-26 | 아카데미아 시니카 | 항-ｃｄ20 글리코항체 및 이의 용도 |
| AU2015267052A1 (en) | 2014-05-27 | 2016-12-15 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| JP7063538B2 (ja) | 2014-05-28 | 2022-05-09 | アカデミア シニカ | 抗ＴＮＦα糖操作抗体群およびその使用 |
| WO2016072806A2 (ko) | 2014-11-06 | 2016-05-12 | 포항공과대학교 산학협력단 | 코어-쉘 구조의 페로브스카이트 나노결정입자 발광체, 이의 제조방법 및 이를 이용한 발광소자 |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| US10808287B2 (en) | 2015-10-23 | 2020-10-20 | Rapid Pathogen Screening, Inc. | Methods and devices for accurate diagnosis of infections |
| CA3024569A1 (en) | 2016-06-22 | 2017-12-28 | Becton, Dickinson And Company | Modular assay reader device |
| AU2017316663B2 (en) | 2016-08-22 | 2024-02-22 | CHO Pharma Inc. | Antibodies, binding fragments, and methods of use |
| US10796901B2 (en) * | 2016-09-29 | 2020-10-06 | Nanoco Technologies Ltd. | Shelling of halide perovskite nanoparticles for the prevention of anion exchange |
| CN110554018A (zh) * | 2018-05-31 | 2019-12-10 | 上海市刑事科学技术研究院 | 检测水溶液中4-溴甲卡西酮的表面增强拉曼材料及其制备方法 |
| CN111686826B (zh) * | 2019-03-15 | 2023-05-23 | 国家纳米科学中心 | 分层结构的微流控芯片及其应用 |
| JP7607312B2 (ja) * | 2020-01-09 | 2024-12-27 | 国立大学法人山梨大学 | 標識化シリカコート金ナノロッド及びその製造方法 |
| WO2021252810A1 (en) | 2020-06-10 | 2021-12-16 | Checkable Medical Incorporated | In vitro diagnostic device |
| TWI756764B (zh) * | 2020-07-31 | 2022-03-01 | 國立中興大學 | 光電流電極及光電免疫感測裝置 |
| WO2022179647A1 (en) * | 2021-02-24 | 2022-09-01 | Univerzita Palackeho V Olomouci | Test strip for surface-enhanced raman spectroscopy, method for its preparation and use thereof |
| US20220317124A1 (en) | 2021-04-01 | 2022-10-06 | Becton Dickinson And Company | Methods for enhancing specificity and sensitivity of group a streptococcus immunoassay |
| TWI792554B (zh) * | 2021-09-10 | 2023-02-11 | 財團法人工業技術研究院 | 鈣鈦礦前驅物溶液檢測法 |
| WO2023055305A1 (en) * | 2021-09-28 | 2023-04-06 | National Science And Technology Development Agency | Qualitative dextran detection device and use thereof |
| CN114720450A (zh) * | 2022-03-29 | 2022-07-08 | 中国工程物理研究院激光聚变研究中心 | 一种新冠病毒拉曼标记型抗原检测试纸条及其制备方法 |
| CN115792216B (zh) * | 2022-11-25 | 2023-11-03 | 中国农业科学院北京畜牧兽医研究所 | 用于检测毒素的侧向层析试纸条、制备方法和使用方法 |
| CN116338169A (zh) * | 2022-12-26 | 2023-06-27 | 北京科技大学 | 以微球反射镜作为探针的显微分析方法 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4920046A (en) * | 1987-02-20 | 1990-04-24 | Becton, Dickinson And Company | Process, test device, and test kit for a rapid assay having a visible readout |
| CA1303983C (en) * | 1987-03-27 | 1992-06-23 | Robert W. Rosenstein | Solid phase assay |
| USRE38430E1 (en) * | 1987-03-27 | 2004-02-17 | Becton, Dickinson And Company | Solid phase chromatographic immunoassay |
| ES2150428T3 (es) * | 1987-04-27 | 2000-12-01 | Unilever Nv | Ensayos de union especifica. |
| CA1313616C (en) * | 1987-06-01 | 1993-02-16 | Robert B. Sargeant | Lateral flow, non-bibulous membrane protocols |
| AU2684488A (en) | 1988-06-27 | 1990-01-04 | Carter-Wallace, Inc. | Test device and method for colored particle immunoassay |
| US6818199B1 (en) * | 1994-07-29 | 2004-11-16 | James F. Hainfeld | Media and methods for enhanced medical imaging |
| US6194220B1 (en) | 1996-09-25 | 2001-02-27 | Becton, Dickinson And Company | Non-instrumented assay with quantitative and qualitative results |
| US5998221A (en) | 1996-09-25 | 1999-12-07 | Becton, Dickinson And Company | Non-instrumented assay with quantitative and qualitative results |
| US5798273A (en) * | 1996-09-25 | 1998-08-25 | Becton Dickinson And Company | Direct read lateral flow assay for small analytes |
| JP2001502052A (ja) * | 1996-09-25 | 2001-02-13 | ユニバーサル ヘルスウォッチ，インコーポレーテッド | 液体移動および干渉に対する抵抗を改良した診断用検査デバイス |
| EP1062510A2 (en) * | 1998-03-10 | 2000-12-27 | Strategic Diagnostics Inc. | Integrated assay device and methods of production and use |
| US6136610A (en) * | 1998-11-23 | 2000-10-24 | Praxsys Biosystems, Inc. | Method and apparatus for performing a lateral flow assay |
| WO2000031538A1 (en) * | 1998-11-23 | 2000-06-02 | Praxsys Biosystems, Inc. | Improved lateral flow assays |
| WO2001018235A2 (en) * | 1999-09-09 | 2001-03-15 | Eichrom Technologies, Inc. | Lateral flow device with metal oxide indicator and assay method employing same |
| ES2296648T3 (es) | 1999-10-06 | 2008-05-01 | Oxonica Inc. | Nanoparticulas compuestas espectroscopicamente activas superficialmente potenciadas. |
| US7052831B2 (en) * | 2000-09-29 | 2006-05-30 | Becton Dickinson And Company | Detection of multiple analytes from a single sample using a multi-well, multi-analyte flow-through diagnostic test device |
| ATE421570T1 (de) * | 2002-06-07 | 2009-02-15 | Cholestech Corp | Automatisierte kassette für eine vorrichtung zur durchführung von immunoanalytischen tests und verfahren zu ihrer verwendung |
| WO2004081568A1 (ja) * | 2003-03-10 | 2004-09-23 | Daiichi Pure Chemicals Co. Ltd. | 検体の検査方法及びその検査方法に用いる検体収容用容器 |
| US7659107B2 (en) * | 2003-09-23 | 2010-02-09 | Epinex Diagnostics, Inc. | Rapid test for glycated albumin |
| US20050148100A1 (en) * | 2003-12-30 | 2005-07-07 | Intel Corporation | Methods and devices for using Raman-active probe constructs to assay biological samples |
| JP2006071520A (ja) * | 2004-09-03 | 2006-03-16 | Enbiotec Laboratories:Kk | Ｐｃｂの簡易検出方法 |
| US7723100B2 (en) | 2006-01-13 | 2010-05-25 | Becton, Dickinson And Company | Polymer coated SERS nanotag |
| WO2007090058A2 (en) * | 2006-01-27 | 2007-08-09 | Oxonica, Inc. | Lateral flow immunoassay with encapsulated detection modality |
-
2009
- 2009-04-08 JP JP2011504156A patent/JP5792614B2/ja active Active
- 2009-04-08 EP EP09730869.6A patent/EP2271939B1/en active Active
- 2009-04-08 WO PCT/US2009/039951 patent/WO2009126735A1/en not_active Ceased
- 2009-04-08 ES ES15172303.8T patent/ES2627190T3/es active Active
- 2009-04-08 BR BRPI0911067A patent/BRPI0911067B8/pt active IP Right Grant
- 2009-04-08 ES ES09730869.6T patent/ES2544257T3/es active Active
- 2009-04-08 AU AU2009233755A patent/AU2009233755B2/en active Active
- 2009-04-08 CN CN200980116000.5A patent/CN102016585B/zh active Active
- 2009-04-08 CA CA2721064A patent/CA2721064C/en active Active
- 2009-04-08 MX MX2010011176A patent/MX2010011176A/es active IP Right Grant
- 2009-04-08 EP EP15172303.8A patent/EP2952897B1/en active Active
- 2009-04-08 US US12/420,574 patent/US20090305231A1/en not_active Abandoned
- 2009-04-08 CN CN201710803380.6A patent/CN107561270B/zh active Active
- 2009-04-09 TW TW098111807A patent/TW200946913A/zh unknown
-
2012
- 2012-10-25 US US13/659,977 patent/US20130281310A1/en not_active Abandoned
-
2015
- 2015-04-24 JP JP2015089316A patent/JP2015148629A/ja active Pending
-
2016
- 2016-09-23 JP JP2016186126A patent/JP6379149B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107561270B (zh) | 2019-06-04 |
| JP2011516889A (ja) | 2011-05-26 |
| JP2015148629A (ja) | 2015-08-20 |
| CN102016585A (zh) | 2011-04-13 |
| CN107561270A (zh) | 2018-01-09 |
| US20090305231A1 (en) | 2009-12-10 |
| BRPI0911067A2 (pt) | 2015-12-29 |
| CA2721064A1 (en) | 2009-10-15 |
| JP5792614B2 (ja) | 2015-10-14 |
| JP6379149B2 (ja) | 2018-08-22 |
| ES2544257T3 (es) | 2015-08-28 |
| BRPI0911067B1 (pt) | 2020-10-20 |
| EP2271939B1 (en) | 2015-06-17 |
| EP2952897A1 (en) | 2015-12-09 |
| AU2009233755A1 (en) | 2009-10-15 |
| WO2009126735A1 (en) | 2009-10-15 |
| CN102016585B (zh) | 2017-10-10 |
| EP2952897B1 (en) | 2017-03-22 |
| US20130281310A1 (en) | 2013-10-24 |
| JP2017015732A (ja) | 2017-01-19 |
| AU2009233755B2 (en) | 2015-11-26 |
| CA2721064C (en) | 2016-11-01 |
| BRPI0911067B8 (pt) | 2021-07-27 |
| MX2010011176A (es) | 2011-02-24 |
| TW200946913A (en) | 2009-11-16 |
| EP2271939A1 (en) | 2011-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2627190T3 (es) | Inmunoensayos sensibles utilizando nanopartículas recubiertas | |
| CN106959370B (zh) | 一种基于耦合光栅的荧光生物传感器及检测方法 | |
| CN105556307B (zh) | 电化学侧向流动生物测定和生物传感器 | |
| US9322823B2 (en) | Method and apparatus for chemical detection | |
| JP5652393B2 (ja) | Ｓｐｆｓ−ｌｐｆｓ系による測定方法に供するプラズモン励起センサおよびアッセイ法 | |
| ES2986595T3 (es) | Métodos de nanosensor y aparatos para la determinación de analitos | |
| JPWO2004036194A1 (ja) | 分析チップおよび分析装置 | |
| WO2016187588A1 (en) | Plasmonic nanoparticles and lspr-based assays | |
| CN103238055A (zh) | 基于磁性粒子的生物传感器 | |
| ES2700602T3 (es) | Una pieza de prueba inmunocromatográfica | |
| US20160209410A1 (en) | Test piece for immunochromatography, developing fluid used therefor, and immunochromatography using the same | |
| JP2010145272A (ja) | プラズモン励起センサを用いたアッセイ法 | |
| ES2536741T3 (es) | Ensayo de unión a base de partículas | |
| Guan et al. | Surface modification of cellulose paper for quantum dot-based sensing applications | |
| US20110195516A1 (en) | Wire grid substrate structure and method for manufacturing such a substrate | |
| CN110114678A (zh) | 生物传感器 | |
| Jelen | Nanogold in Rapid Tests | |
| JP2009222562A (ja) | 測定チップとそれを用いた測定方法 | |
| KR20110105538A (ko) | 졸-겔(ｓｏｌ-ｇｅｌ) 조성물을 이용한 카트리지 및 카트리지 리더의 제어방법 |